| DLI |
|
| Hematological malignancies (14) |
NCT02673008, NCT01240525, NCT02458235, NCT02568241, NCT02328885, NCT02331706, NCT01839916, NCT02452697, NCT01982682, NCT03032783, NCT02566395, NCT01384513, NCT02566304, NCT02199041
|
| MDS/AML (7) |
NCT02856464, NCT02472691, NCT02046122, NCT02684162, NCT01369368, NCT01758367, NCT02888522
|
| CLL (1) |
NCT01849939 |
| Myeloma (2) |
NCT01131169, NCT02700841
|
| CTL |
|
| Hematological malignancies (2) |
NCT02895412, NCT02203903
|
| EBV-associated malignancies (1) |
NCT00002663 |
| CIK |
|
| Leukemia/MDS (2) |
NCT02752243, NCT01898793
|
| Lymphoma (2) |
NCT02497898, NCT01799083
|
| MIL |
|
| Myeloma (1) |
NCT01858558 |
| CART |
|
| CD5 directed (1) |
NCT03081910 |
| CD19 directed (60) |
NCT02935543, NCT02445222, NCT02547948, NCT03142646, NCT02799550, NCT02782351, NCT02813837, NCT03029338, NCT03121625, NCT03027739, NCT02640209, NCT03086954, NCT02822326, NCT02975687, NCT01864889, NCT02735291, NCT02728882, NCT02963038, NCT03101709, NCT02924753, NCT02247609, NCT03068416, NCT02810223, NCT02965092, NCT02186860, NCT02935257, NCT02842138, NCT03064269, NCT02537977, NCT02672501, NCT02624258, NCT02794246, NCT02652910, NCT03085173, NCT02443831, NCT02819583, NCT03110640, NCT03118180, NCT02685670, NCT02030834, NCT02349698, NCT02529813, NCT02081937, NCT02030847, NCT02028455, NCT02968472, NCT03016377, NCT02546739, NCT03050190, NCT02772198, NCT03103971, NCT02228096, NCT02851589, NCT02146924, NCT01853631, NCT02374333, NCT02659943, NCT01865617, NCT02445248, NCT02631044
|
| CD20 directed (3) |
NCT02710149, NCT02965157, NCT01735604
|
| CD22 directed (4) |
NCT02794961, NCT02935153, NCT02650414, NCT02721407
|
| CD30 directed (6) |
NCT02259556, NCT02917083, NCT02958410, NCT02274584, NCT03049449, NCT02690545
|
| CD33 directed (4) |
NCT01864902, NCT02799680, NCT02958397, NCT03126864
|
| CD123 directed (3) |
NCT02937103, NCT03114670, NCT02159495
|
| CD133 directed (1) |
NCT02541370 |
| CD138 directed (1) |
NCT01886976 |
| BCMA directed (5) |
NCT02954445, NCT02546167, NCT03070327, NCT03093168, NCT02215967
|
| LeY directed (1) |
NCT02958384 |
| ROR1 (1) |
NCT02706392 |
| Combination (4) |
NCT02903810, NCT03125577, NCT03098355, NCT03097770
|
| Vaccines |
|
| MDS/AML (8) |
NCT01686334, NCT02493829, NCT03059485, NCT01734304, NCT02405338, NCT01773395, NCT03083054, NCT02498665
|
| CML (2) |
NCT02543749, NCT00363649
|
| CLL (1) |
NCT02802943 |
| Myeloma (1) |
NCT02334865 |
| NHL (1) |
NCT03035331 |
| NK cells |
|
| Hematological malignancies (12) |
NCT02280525, NCT02892695, NCT01619761, NCT01904136, NCT03056339, NCT02742727, NCT01823198, NCT00720785, NCT02727803, NCT01700946, NCT01807611, NCT02890758
|
| MDS/AML (14) |
NCT01787474, NCT02809092, NCT02763475, NCT03081780, NCT02123836, NCT03050216, NCT02229266, NCT02944162, NCT02477787, NCT02782546, NCT01898793, NCT03068819, NCT02316964, NCT02781467
|
| ALL (2) |
NCT02185781, NCT01974479
|
